Takeda Mulls Sale of $3 Billion in Emerging-Market Assets
The Takeda Pharmaceutical Co. logo is displayed at the company’s global headquarters in Tokyo, Japan. (Photographer: Kentaro Takahashi/Bloomberg)

Takeda Mulls Sale of $3 Billion in Emerging-Market Assets

(Bloomberg) -- Takeda Pharmaceutical Co. is considering a sale of some emerging-market drugs, as the Japanese drugmaker expands a push to cut debt after its $62 billion takeover of Shire Plc, peopl...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.